Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robots with skin and stem cells get paid in crypto to work in hospitals

NCT ID NCT07214896

Disease control Sponsor: Truway Health, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing humanoid robots in healthcare settings to see if they can help with patient care, cleaning, and paperwork. The robots are upgraded with lab-grown skin and stem cells to improve their touch and learning, and they earn digital tokens based on their performance. About 400 healthcare workers and staff will interact with these robots over 90 days to measure how well they work and whether they meet environmental and safety goals.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Humanoid robots enhanced with lab-grown skin cells and stem cells, plus blockchain-based wage tokens
What this could lead to
If successful, this could show that humanoid robots can safely assist with patient care, cleaning, and administrative tasks in hospitals, potentially improving efficiency and reducing human workload.
What could go wrong
This is an early-stage trial with only 400 participants, and it focuses on robot performance rather than direct patient health outcomes. The biotech enhancements and token system are experimental, and long-term safety or effectiveness is not yet known.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2

Tests whether the treatment actually works, and watches for side effects, in a larger group.

Participants

About 400 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Oct 2031

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: \- Age 18-75 years Able to provide informed consent Facility staff, clinical auditors, ESG observers, or coalition stakeholders Willing to interact with humanoid robotics in clinical workflows Available for biometric feedback and observational logging over 90 days Exclusion Criteria: \- Cognitive impairment preventing informed consent Active infectious disease requiring isolation Prior adverse reaction to biotech-enhanced robotics Involvement in conflicting clinical trials Inability to comply with protocol procedures or coalition transparency requirements

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Clinical workflow optimization are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Clinical workflow optimization Esg-linked healthcare robotics deployment Mobility impairment Sanitation protocol compliance

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites in 3 countries. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Coalition Retrofit Clinic - Austin, TX

    Austin, Texas, 73301, United States

  • ESG Compliance Lab

    Frankfurt, 60435, Germany

  • Public Interface Pilot

    Tokyo, 100-1000, Japan

  • Truway Health, Inc. , View 34, 401 E 34th Street, S11P, New York, NY 10016

    New York, New York, 10016, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.